Ready to Jump After Recent Trade: Novavax, Inc. (NVAX)

With 4.43 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.56 million shares. The 52-week range on NVAX shows that it touched its highest point at $11.36 and its lowest point at $3.53 during that stretch. It currently has a 1-year price target of $15.40. Beta for the stock currently stands at 1.61.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NVAX was down-trending over the past week, with a drop of -5.82%, but this was down by -15.96% over a month. Three-month performance dropped to -5.62% while six-month performance fell -37.43%. The stock lost -31.26% in the past year, while it has lost -5.62% so far this year. A look at the trailing 12-month EPS for NVAX yields -5.54 with Next year EPS estimates of 0.12. For the next quarter, that number is -0.95. This implies an EPS growth rate of 85.27% for this year and 115.48% for next year.

Float and Shares Shorts:

At present, 139.51 million NVAX shares are outstanding with a float of 131.81 million shares on hand for trading. On Mar 15, 2024, short shares totaled 48.13 million, which was 34.39% higher than short shares on Feb 15, 2024. In addition to NVAX as the firm’s Novavax, Inc., DVAX serves as its Dynavax Technologies Corporatio.

Institutional Ownership:

Through their ownership of 56.31% of NVAX’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NVAX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, NVAX has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and NVAX currently yields $0.00. In the past year, NVAX’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, NVAX has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.